Literature DB >> 9764555

Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis.

H Rinder1, A Thomschke, S Rüsch-Gerdes, G Bretzel, K Feldmann, M Rifai, T Löscher.   

Abstract

To determine the value of ahpC promoter mutations for the rapid prediction of isoniazid resistance, this genomic region was characterized in 50 isoniazid-resistant and 12 isoniazid-sensitive Mycobacterium tuberculosis isolates. Of the resistant isolates, 12 had ahpC promoter mutations, but only one possessed both an ahpC promoter mutation and a katG codon 315 substitution, although the latter was found in the majority (54%) of the isoniazid-resistant isolates investigated. This investigation presents empirical evidence that the central portion of the ahpC promoter is the most valuable genetic locus to complement katG codon 315 characterizations in order to increase the sensitivity of molecular tests for the prediction of isoniazid resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764555     DOI: 10.1007/bf01691135

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.

Authors:  S Dhandayuthapani; Y Zhang; M H Mudd; V Deretic
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

2.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  C L Kelley; D A Rouse; S L Morris
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.

Authors:  S Sreevatsan; X Pan; Y Zhang; V Deretic; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.

Authors:  Y Zhang; S Dhandayuthapani; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  B Heym; E Stavropoulos; N Honoré; P Domenech; B Saint-Joanis; T M Wilson; D M Collins; M J Colston; S T Cole
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

7.  ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex.

Authors:  T M Wilson; D M Collins
Journal:  Mol Microbiol       Date:  1996-03       Impact factor: 3.501

8.  Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.

Authors:  J M Musser; V Kapur; D L Williams; B N Kreiswirth; D van Soolingen; J D van Embden
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

9.  Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.

Authors:  D R Sherman; P J Sabo; M J Hickey; T M Arain; G G Mahairas; Y Yuan; C E Barry; C K Stover
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance.

Authors:  F R Cockerill; J R Uhl; Z Temesgen; Y Zhang; L Stockman; G D Roberts; D L Williams; B C Kline
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  9 in total

1.  Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis.

Authors:  Márcia Susana N Silva; Simone G Senna; Marta O Ribeiro; Andréia R M Valim; Maria Alice Telles; Afrânio Kritski; Glenn P Morlock; Robert C Cooksey; Arnaldo Zaha; Maria Lucia R Rossetti
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism.

Authors:  L V Baker; T J Brown; O Maxwell; A L Gibson; Z Fang; M D Yates; F A Drobniewski
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Immunometabolism during Mycobacterium tuberculosis Infection.

Authors:  Nicole C Howard; Shabaana A Khader
Journal:  Trends Microbiol       Date:  2020-05-11       Impact factor: 17.079

4.  Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China.

Authors:  Tao Luo; Ming Zhao; Xia Li; Peng Xu; Xiaohong Gui; Sam Pickerill; Kathryn DeRiemer; Jian Mei; Qian Gao
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

5.  HIV evades RNA interference directed at TAR by an indirect compensatory mechanism.

Authors:  Joshua N Leonard; Priya S Shah; John C Burnett; David V Schaffer
Journal:  Cell Host Microbe       Date:  2008-11-13       Impact factor: 21.023

Review 6.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

Review 7.  Drug Resistance Mechanisms in Mycobacterium tuberculosis.

Authors:  Juan Carlos Palomino; Anandi Martin
Journal:  Antibiotics (Basel)       Date:  2014-07-02

8.  Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Authors:  Li-Li Zhao; Ming-Xiang Huang; Tong-Yang Xiao; Hai-Can Liu; Ma-Chao Li; Xiu-Qin Zhao; Zhi-Guang Liu; Yi Jiang; Kang-Lin Wan
Journal:  Infect Drug Resist       Date:  2019-08-07       Impact factor: 4.003

Review 9.  Multidrug-resistant tuberculosis.

Authors:  Antônio Carlos Moreira Lemos; Eliana Dias Matos
Journal:  Braz J Infect Dis       Date:  2013-03-09       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.